Heel-prick blood samples from newborns can be used to measure antibodies against group B Streptococcus, according to a new study from Aarhus University published in The Lancet Microbe journal. In the longer term, the method could contribute to the development of vaccines designed to protect infants against serious infections.
❓ Unknown
Heel-prick Blood Samples May Lead to Vaccines for Newborn Infection Protection
Just now
October 2, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
Aarhus University conducted a study showing that heel-prick blood samples from newborns can measure antibodies against group B Streptococcus, potentially aiding in vaccine development for serious infections. This research could have implications for public health strategies in Iran, particularly in improving infant healthcare.
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
Just now •
Three Executed in Isfahan: A Woman for Murder and Two Men for Drug Offenses
10 min ago •
Iran Condemns Trump's Indifference to Human Cost of US-Israeli Aggression
11 min ago •
University of Newcastle Develops Smart Silicone Coatings with Adjustable Friction
11 min ago •
Health Benefits of Very Low-Carbohydrate Diets for Children with Type 1 Diabetes
11 min ago •